Nicolás Maneiro Melón

Nicolás Maneiro Melón

Auto-generated profile, based on publicly available information

Nicolás Maneiro Melón

Hospital Universitario 12 de Octubre

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 May 2020 in European Heart Journal
Verified
Journal Article
Closed access
LGLucia Fernandez Gasso
Lucia Fernandez Gasso
NMNicolas M Maneiro Melon
Nicolas M Maneiro Melon
FCFernando Sarnago Cebada
Fernando Sarnago Cebada
JSJorge Solis
Jorge Solis
JTJulio Garcia Tejada
Julio Garcia Tejada

1 January 2025 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
MAMarisa Avvedimento
Marisa Avvedimento
PCPedro Luis Cepas-Guillen
Pedro Luis Cepas-Guillen
JTJulien Ternacle
Julien Ternacle
MUMarina Urena
Marina Urena
AAAlberto Alperi
Alberto Alperi
JRJosep Rodés-Cabau
Josep Rodés-Cabau
BACKGROUND: The Valve Academic Research Consortium for High Bleeding Risk (VARC-HBR) has recently introduced a consensus document that outlines risk factors to identify high bleeding risk in patients undergoing transcatheter aortic valve replacement. The objective of the present study was to evaluate the prevalence and predictive value of the VARC-HBR definition in a contemporary, large-scale transcatheter aortic valve replacement population. METHODS: Multicenter study including 10 449 patients undergoing transcatheter aortic valve replacement. Based on consensus, 21 clinical and laboratory criteria were identified and classified as major or minor. Patients were stratified as at low, moderate, high, and very high bleeding risk according to the VARC-HBR definition. The primary end point was the rate of Bleeding Academic Research Consortium type 3 or 5 bleeding at 1 year, defined as the composite of periprocedural (within 30 days) or late (after 30 days) bleeding. RESULTS: Patients with at least 1 VARC-HBR criterion (n=9267, 88.7%) had a higher risk of Bleeding Academic Research Consortium 3 or 5 bleeding, proportional to the severity of risk assessment (10.8%, 16.1%, and 24.6% for moderate, high, and very-high-risk groups, respectively). However, a comparable rate of bleeding events was observed in the low-risk and moderate-risk groups. The area under receiver operating characteristic curve was 0.58. Patients with VARC-HBR criteria also exhibited a gradual increase in 1-year all-cause mortality, with an up to 2-fold increased mortality risk for high and very-high-risk groups (hazard ratio, 1.33 [95% CI, 1.04–1.70] and 1.97 [95% CI, 1.53–2.53], respectively). CONCLUSIONS: The VARC-HBR consensus offered a pragmatic approach to guide bleeding risk stratification in transcatheter aortic valve replacement. The results of the present study would support the predictive validity of the new definition and promote its application in clinical practice to minimize bleeding risk and improve patient outcomes.

Verified
Journal Article
Open access
PDF file
MMMª Teresa Velázquez Martín
Mª Teresa Velázquez Martín
NMNicolás Maneiro
Nicolás Maneiro
ALAna Lareo
Ana Lareo
AAAgustín Albarrán
Agustín Albarrán
SHSergio Huertas
Sergio Huertas
PEP. Escribano-Subias
P. Escribano-Subias
With the advent of balloon pulmonary angioplasty (BPA) for non-surgical chronic thromboembolic pulmonary hypertension (CTEPH) patients, there is renewed interest in the pulmonary angiography technique. This technique is still the standard imaging modality to confirm CTEPH, which, in addition, helps to determine the most appropriate treatment. Furthermore, learning this technique fulfills two main purposes: to identify BPA candidates and to provide the operator with the catheter handling needed to perform BPA. Operators interested in performing BPA must learn not only the pulmonary arteries’ anatomy, but also which are the best angiographic projections and the most suitable catheters to canalize and display each segmental branch. Unfortunately, this information is scarce in the literature. With this goal, learning the diagnostic pulmonary angiography technique can be a first step on the way to perform BPA. Although there are descriptions on how to perform a pulmonary angiography with balloon-tipped catheters and the digital subtraction technique, this technique does not provide operators with the catheter knowledge and manual skill needed to cannulate each segmental branch. In contrast, learning the conventional selective segmental pulmonary angiography (SSPA) technique provides the operator with this knowledge and skills. In this review, based on the experience of the authors, we describe the pulmonary arteries’ anatomy and detail the practical aspects of the SSPA procedure, with the aim of providing operators with the anatomical and technical knowledge needed to perform BPA. We also summarize the contemporary complications of SSPA in CTEPH patients at a reference center.

1 September 2023 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
SNSergio Huertas Nieto
Sergio Huertas Nieto
MMMª Teresa Velázquez Martín
Mª Teresa Velázquez Martín
FCFernando Sarnago Cebada
Fernando Sarnago Cebada
CLCarmen Jimenez Lopez-Guarch
Carmen Jimenez Lopez-Guarch
NMNicolás Maneiro Melón
Nicolás Maneiro Melón
PEP. Escribano-Subias
P. Escribano-Subias

23 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
NMNicolas M. Maneiro Melon
Nicolas M. Maneiro Melon
MMMª Teresa Velázquez Martín
Mª Teresa Velázquez Martín
SNSergio Huertas Nieto
Sergio Huertas Nieto
AGAgustin Albarran Gonzalez-Trevilla
Agustin Albarran Gonzalez-Trevilla
FCFernando Sarnago Cebada
Fernando Sarnago Cebada
PEP. Escribano-Subias
P. Escribano-Subias
(1) Background: Pulmonary endarterectomy (PEA) is the “gold standard” treatment for operable patients with chronic thromboembolic pulmonary hypertension (CTEPH). Persistent pulmonary hypertension (PH) after PEA confers a worse prognosis. Balloon pulmonary angioplasty (BPA) could represent a useful therapy in this setting, but evidence about its effectiveness and safety in patients with previous PEA is limited. (2) Methods: A total of 14 patients with persistent PH after PEA were treated with BPA in a single PH center. Hemodynamic and clinical effects of BPA and complications of the procedure were retrospectively collected. (3) Results: After BPA, the mean pulmonary arterial pressure fell from 50.7 ± 15.3 mmHg to 38.0 ± 7.9 mmHg (25.0% decrease; 95% confidence interval (CI) 14.0–35.5%; p = 0.01). Pulmonary vascular resistances were reduced from 8.5 ± 3.6 WU to 5.3 ± 2.2 WU (37.6% decrease; 95% CI 18.8–56.5%; p = 0.01). WHO functional class was also improved with BPA. Severe BPA-related complications were infrequent and no periprocedural deaths were observed. (4) Conclusions: BPA is an effective and safe therapy for patients with CTEPH and persistent PH after PEA.

1 February 2026 in Cardiovascular Diagnosis and Therapy
Verified
Journal Article
Open access
PDF file
GMGonzalo García Martí
Gonzalo García Martí
MMMª Teresa Velázquez Martín
Mª Teresa Velázquez Martín
NMNicolás Maneiro Melón
Nicolás Maneiro Melón
PSPablo Salinas
Pablo Salinas
Background and Objective: Catheter-directed interventions (CDI) for pulmonary embolism (PE) have emerged as alternatives to systemic thrombolysis for patients requiring reperfusion, enabling thrombus burden reduction through low-dose local thrombolysis or mechanical thrombectomy. Despite encouraging hemodynamic and clinical outcomes, procedure-specific complications are poorly characterized in the literature. This narrative review aims to synthesize the reported complications of CDI in acute PE and provide practical management strategies. Methods: A PubMed search covering 2014–2025, limited to articles published in English or Spanish, complemented by reference screening, identified randomized clinical trials and prospective or retrospective registries of CDI in acute PE reporting safety outcomes. These studies were used to construct a comprehensive overview of CDI-related complications, while additional registries, case reports, and case series were examined to describe rare events not captured by primary studies, as well as expert insights when evidence was insufficient or unavailable. Key Content and Findings: Complications of CDI in acute PE encompass a broad and heterogeneous spectrum including access-site complications, right-heart injury, pulmonary arterial lesions, catheter malfunction and mechanical complications, and hemodynamic deterioration. Their incidence varies considerably across studies, and the absence of standardized definitions or classifications limits accurate assessment of the true frequency and clinical impact of those adverse events. Conclusions: Based on the available evidence, this narrative expert review examines the spectrum of CDI-related complications in acute PE. It seeks to bridge the gap between innovation and safety by equipping clinicians and interventionalists with practical guidance for the recognition, prevention, and management of these adverse events.